Patient-reported pain and other symptoms as prognostic factors for overall survival (OS) in a phase III clinical trial of patients with advanced breast cancer. This is an ASCO Meeting Abstract from ...
Introduction Integrating smoking cessation supports into lung cancer screening can improve abstinence rates. However, ...
Biosimilar DMARDs offer cost-effective and improved outcomes over leflunomide for RA patients unresponsive to methotrexate. The study used a Markov model with data from 25,099 RA patients to simulate ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback